The specific serotonin reuptake inhibitor (SSRI) fluoxetine increases miR-16 and diminishes SERT expression in the raphe nuclei, and miR-16 overexpression copies the antidepressant impacts of fluoxetine in mouse models of depression. The gene discussed is SLC6A4; the disease is depressive symptom measurement.